Tower Research Capital (TRC)’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12K | Sell |
208
-13
| -6% | -$133 | ﹤0.01% | 4695 |
|
|
2025
Q1 | $1.72K | Sell |
221
-1
| -0.5% | -$8 | ﹤0.01% | 4662 |
|
|
2024
Q4 | $3.62K | Buy |
222
+119
| +116% | +$1.94K | ﹤0.01% | 4625 |
|
|
2024
Q3 | $3.92K | Sell |
103
-104
| -50% | -$3.96K | ﹤0.01% | 4736 |
|
|
2024
Q2 | $9.31K | Buy |
207
+64
| +45% | +$2.88K | ﹤0.01% | 4265 |
|
|
2024
Q1 | $7.03K | Buy |
+143
| New | +$7.03K | ﹤0.01% | 4276 |
|
|
2023
Q4 | – | Sell |
-355
| Closed | -$10.6K | – | 5907 |
|
|
2023
Q3 | $10.6K | Buy |
355
+133
| +60% | +$3.99K | ﹤0.01% | 4089 |
|
|
2023
Q2 | $11.8K | Buy |
222
+77
| +53% | +$4.09K | ﹤0.01% | 3906 |
|
|
2023
Q1 | $10K | Hold |
145
| – | – | ﹤0.01% | 4315 |
|
|
2022
Q4 | $12K | Hold |
145
| – | – | ﹤0.01% | 3667 |
|
|
2022
Q3 | $9K | Buy |
145
+57
| +65% | +$3.54K | ﹤0.01% | 4627 |
|
|
2022
Q2 | $7K | Sell |
88
-78
| -47% | -$6.21K | ﹤0.01% | 4754 |
|
|
2022
Q1 | $11K | Buy |
+166
| New | +$11K | ﹤0.01% | 4136 |
|
|
2021
Q4 | – | Sell |
-35
| Closed | -$4K | – | 6092 |
|
|
2021
Q3 | $4K | Buy |
35
+12
| +52% | +$1.37K | ﹤0.01% | 4947 |
|
|
2021
Q2 | $3K | Buy |
+23
| New | +$3K | ﹤0.01% | 4897 |
|